BME100 f2013:W900 Group18 L2
From OpenWetWare
BME 100 Fall 2013  Home People Lab WriteUp 1  Lab WriteUp 2  Lab WriteUp 3 Lab WriteUp 4  Lab WriteUp 5  Lab WriteUp 6 Course Logistics For Instructors Photos Wiki Editing Help  
OUR TEAMLAB 2 WRITEUPDescriptive StatisticsExperiment 1: Human Study 5mg: 10mg: 15mg:
Experiment 2: Rat Study 10mg: This section was worked on by Dylan, Daniel, and Nick.
Results
AnalysisIn the first experiment with humans, an ANOVA test was conducted resulting in a pvalue of 1.40E16. After Bonferonni correction, the new alpha level was set at 8.33E3 (rather than .05). Since the pvalue was less than 8.33E3, we can conclude that there is a statistically significant difference between levels of dosage of LPS in humans. In the second experiment with rats, a Ttest was conducted resulting in a pvalue of .8674035. Since the pvalue was greater than .05, we can conlude that there is no statistically significant difference between levels of LPS dosage in rats. Worked on by Daniel and Dylan
Summary/DiscussionIt was concluded that there is a statiscally significant difference in the Inflammotin levels in humans when the dosage of LPS is increased. In humans, the doses of LPS between 0mg and 10mg produced less variance of Inflammotin levels than when a dose of 15 mg was given to the subjects. However, when the experiment was repeated on rats, the increase in the dosage of LPS did not yield as large of a difference in Inflammotin levels. Providing the human subjects with 15mg of LPS caused them to produce over 100 times the amount of Inflammotin that occurred when giving them 0mg to 10mg. After testing the rats, the results yielded a pvalue of .8674035, meaning the results were insignifcant because the pvalue was greater than .05 (averages were too close together). Worked on by Kirstin Peters & Matt Hanson & Nick Vale
